{
    "Trade/Device Name(s)": [
        "Audit\u00ae MicroLQ\u2122 Serum Protein Control"
    ],
    "Submitter Information": "Aalto Scientific, Ltd.",
    "510(k) Number": "K112705",
    "Predicate Device Reference 510(k) Number(s)": [
        "K101216"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "JJY"
    ],
    "Summary Letter Date": "November 22, 2011",
    "Summary Letter Received Date": "November 23, 2011",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Quality Control Material (Assayed and Unassayed)"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "immunology"
    ],
    "Analyte(s)": [
        "Immunoglobulin E (IgE)",
        "Immunoglobulin M (IgM)",
        "Immunoglobulin G (IgG)",
        "Immunoglobulin A (IgA)",
        "Prealbumin",
        "Antithrombin III",
        "Alpha-1-Antitrypsin (AAT)",
        "Albumin",
        "Complement C4 (C4)",
        "Complement C3 (C3)",
        "Alpha-2-Macroglobulin",
        "Alpha-1-Acid Glycoprotein",
        "Ceruloplasmin",
        "Transferrin",
        "Haptoglobin",
        "Beta-2-Microglobulin"
    ],
    "Specimen Type(s)": [
        "Human serum (control material)"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Beckman Immage 800"
    ],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Control",
        "Quality control material"
    ],
    "Document Summary": "FDA 510(k) summary for Audit\u00ae MicroLQ\u2122 Serum Protein Control, a human serum-based liquid quality control material for serum protein analytes",
    "Indications for Use Summary": "Assayed, ready-to-use human serum control for monitoring precision of laboratory assays quantitating specified serum proteins, used with Beckman Immage 800 analyzer",
    "fda_folder": "Clinical Chemistry"
}